Clinical Trials
4 trialsNCT00085878 2008-10-16
Dose-Escalation Study Of SB-485232 Administered As Daily Subcutaneous Injections In Adults With Solid Tumors
GlaxoSmithKline
Phase 1 Completed
NCT00119171 2008-10-16
Ispinesib In Combination With Capecitabine In Patients With Solid Tumors
GlaxoSmithKline
Phase 1 Completed
NCT00136513 2008-10-16
SB-743921 In Patients With Solid Tumors
GlaxoSmithKline
Phase 1 Completed
NCT00169520 2008-10-16
SB-715992 In Combination With Docetaxel In Patients With Solid Tumors
GlaxoSmithKline
Phase 1 Completed